首页 | 本学科首页   官方微博 | 高级检索  
     

特发性肺纤维化患者死亡预后因素的回顾性队列研究
引用本文:李振华,彭守春,康健,侯显明,于润江. 特发性肺纤维化患者死亡预后因素的回顾性队列研究[J]. 中华结核和呼吸杂志, 2010, 33(12)
作者姓名:李振华  彭守春  康健  侯显明  于润江
作者单位:中国医科大学附属第一医院呼吸疾病研究所,沈阳,110001
摘    要:
目的 探讨特发性肺纤维化(IPF)患者的临床、影像学和肺生理学指标与疾病预后的关系.方法 2000年1月至2004年6月在中国医科大学附属第一医院126例经临床诊断的IPF患者作为研究对象,其中男81例,女45例,年龄51~67岁,平均61岁.采用单因素和多因素Cox比例风险回归分析评估患者临床、呼吸生理、BALF及HRCT等参数的死亡风险度,采用Kaplan-Meier检验比较组间生存率.结果平均随访时间为29.6个月,IPF患者的生存率为46.8%(59/126),确诊后的中位生存期为30个月.采用糖皮质激素和(或)细胞毒类药物治疗与采用其他药物治疗的生存率比较,差异无统计学意义(Ward值为2.3,P>0.05);性别和吸烟状态的组间生存率比较,差异无统计学意义(Ward值为0.11和1.65,均P>0.05).将单因素Cox比例风险回归分析结果中有意义的变量中位数为截点值,进行组间生存率比较,结果表明,呼吸困难评分、FVC、肺总量、DLCO、BALF中性粒细胞、嗜酸粒细胞、胸部HRCT网格影和蜂窝肺的组间生存率差异均有统计学意义(Logrank值为13.52~57.52,均P<0.05).多因素Cox比例风险回归分析结果表明,肺总量、DLCO、HRCT网格影和蜂窝肺均为影响IPF患者预后的因素(Ward值为5.76~74.20,均P<0.01).结论 肺总量、DLCO、BALF细胞学指标和肺纤维化程度是影响IPF患者预后的主要因素,其中肺总量和DLCO与IPF患者的预后呈负相关.糖皮质激素和(或)细胞毒类药物不能改变IPF患者的预后.

关 键 词:肺纤维化  支气管肺泡灌洗液  预后

A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis
LI Zhen-hua,PENG Shou-chun,KANG Jian,HOU Xian-ming,YU Run-jiang. A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis[J]. Chinese journal of tuberculosis and respiratory diseases, 2010, 33(12)
Authors:LI Zhen-hua  PENG Shou-chun  KANG Jian  HOU Xian-ming  YU Run-jiang
Abstract:
Objective To investigate the prognostic implications of clinical,radiographic,and physiological variables in idiopathic pulmonary fibrosis (IPF).Methods The clinical,pulmonary physiological,bronchoalveolar lavage fluid (BALF) cell differentials and lung high-resolution computed tomography (HRCT) at diagnosis in 126 patients with IPF were retrospectively analyzed.Univariate and multivariate Cox proportional-hazards regression analysis was used to evaluate various parameters associated with hazard ratio (HR).The survival rates of all groups were compared using the Kaplan-Meier method.Results In 29.6 months of average follow-up time,the survival rate of the IPF patients was 46.8% (59/126),and the median survival time was 30 months after diagnosis.Glucocorticoids and/or cytotoxic drugs for patients with IPF did not change the prognosis.The survival rates between groups by gender and smoking status showed no statistically significant difference (Ward:0.11,1.65,P>0.05).The patients were divided into 2 groups by the median (the cutoff point value)of significant variables in univariate Cox proportional-hazards regression analysis,and the survival rates showed statistically significant difference by dyspnea scale,FVC%,TLC%,DLCO%,neutrophil percentage and eosinophil percentate in BALF,and the reticular and honeycomb lung score (Logrank:13.52-57.52,P<0.05).The results of multivariate Cox proportional-hazards regression analysis showed that TLC%,DLCO%,HRCT reticular score and honeycomb lung score were factors that affected the prognosis of patients with IPF (Wald=5.76-21.48,P<0.05).Conclusions TLC%,DLCO%,cell differentials of BALF and the degree of pulmonary fibrosis were the main factors affecting the prognosis of patients with IPF.TLC% and DLCO% showed a negative correlation with the prognosis of patients with IPF.Glucocorticoids and/or cytotoxic drug therapy had no effect on the prognosis of patients with IPF.
Keywords:Pulmonary fibrosis  Bronchoalveolar lavage fluid  Prognosis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号